Impax Laboratories, Inc. (NASDAQ:IPXL) has a 0 daily sentiment score given by Alpha One after scanning articles on various online news platform. Alpha One performs algorithm based analysis to reach stock
Impax Laboratories, Inc. (NASDAQ:IPXL)‘s stock had its “sector perform” rating reissued by RBC Capital Markets in a note issued to investors on Tuesday. IPXL has been the subject of several other research reports. …
Thecer2mon
Impax stock has a low valuation from the recent steep sell-off ... epinephrine injector pen for only $109.99 for a 2-pack. Impax Laboratories (NASDAQ:IPXL) is set to benefit as the company produces the generic version of …
Impax Laboratories
The average and low price target for the stock are $18.47 and $12, respectively. Showing a price of $14.25, Impax Labs (NASDAQ:IPXL) traded -34.74% lower on the day. 7,805,115 shares of the company were exchanged. …
Impax Laboratories Inc. (NASDAQ:IPXL) will report its next earnings on 1-Mar-17 ... Laboratories Inc. and for the current quarter 16 analysts have projected that the stock could give an Average Earnings estimate of …
Oracle Corporation
One such stock that you may want to consider dropping is Impax Laboratories Inc. IPXL, which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the …
ten have issued a hold rating and three have assigned a buy rating to the stock. Sell-side analyst recommendations point to a short term price target of $52.45 on the company shares. Showing a price of …
No shares are being sold by the Company. Assuming the completion of …
CAT-1
Impax Laboratories, Clearside Biomedical and Mylan were among the biotech stock movers in premarket trading Wednesday. It's unclear how much of the hefty $4,500 price pharmacy benefit managers or insurers will agree …